Faridabad Diagnostic Centre Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 20-12-2024
- Paid Up Capital ₹ 1.26 M
as on 20-12-2024
- Company Age 27 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.36 M
as on 20-12-2024
- Satisfied Charges ₹ 1.12 M
as on 20-12-2024
- Revenue %
(FY 2022)
- Net Worth 36.01%
(FY 2022)
- Total Assets 14.14%
(FY 2022)
About Faridabad Diagnostic Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.26 M.
The company currently has active open charges totaling ₹0.36 M. The company has closed loans amounting to ₹1.12 M, as per Ministry of Corporate Affairs (MCA) records.
Bhuvanesh Gupta and Rani Gupta serve as directors at the Company.
- CIN/LLPIN
U85195HR1997PTC092200
- Company No.
086377
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Faridabad Diagnostic Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhuvanesh Gupta  | Director | 02-Apr-1997 | Current |
| Rani Gupta | Director | 02-Apr-1997 | Current |
Financial Performance of Faridabad Diagnostic Centre.
Faridabad Diagnostic Centre Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 36.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Faridabad Diagnostic Centre?
In 2021, Faridabad Diagnostic Centre had a promoter holding of 75.66% and a public holding of 24.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
City Central Laboratories Private LimitedActive 17 years 8 monthsBhuvanesh Gupta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 11 Jan 2003 | ₹0.21 M | Open |
Union Bank Of India Creation Date: 25 Apr 2002 | ₹0.15 M | Open |
Others Creation Date: 22 Dec 2017 | ₹0.60 M | Satisfied |
How Many Employees Work at Faridabad Diagnostic Centre?
Unlock and access historical data on people associated with Faridabad Diagnostic Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Faridabad Diagnostic Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Faridabad Diagnostic Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
